Lyophilised hGH Fragment 176–191, 5 mg, with 3 mL bacteriostatic water in a research laboratory.
Buy Alpha-PiHP (a-PiHP) Price range: €15.95 through €1,699.95
Back to products
Lyophilised hGH Fragment 176–191, 5 mg, with 3 mL bacteriostatic water in a research laboratory.
Buy NEP (N-Ethylpentedrone) Price range: €14.95 through €3,097.95

Buy MDPHP Powder (freebase)

Price range: €16.00 through €1,737.50

Certified high-purity MDPHP freebase (≥99%) for analytical and in vitro laboratory research. Rigorously tested, batch-specific CoA provided. Fast, discreet EU shipping from Pharma Research .eu.

Quantity

1 gram

,

2 grams

,

5 grams

,

10 grams

,

25 grams

,

50 grams

,

100 grams

,

250 grams

SKU: N/A Category:
Description

Buy MDPHP Powder (Freebase) for Advanced Laboratory Research in Europe

3′,4′-Methylenedioxy-α-pyrrolidinohexanophenone (MDPHP) represents a critical pyrrolidinophenone-type synthetic cathinone for contemporary neuropharmacological and forensic analytical research across European laboratories. As the definitive EU source for rigorously characterised research chemicals, Pharma Research .eu supplies this high-purity analytical reference standard exclusively to qualified institutional researchers conducting in vitro investigations and method validation studies. Our commitment to scientific rigour ensures every batch meets the exacting standards demanded by publishable, reproducible research outcomes.

Uncompromising Purity and Analytical Characterisation

Pharma Research .eu guarantees a minimum purity of ≥99% for all MDPHP freebase batches, verified through orthogonal analytical methodologies including High-Performance Liquid Chromatography (HPLC), Gas Chromatography–Mass Spectrometry (GC-MS), and Nuclear Magnetic Resonance (NMR) spectroscopy. Every shipment is accompanied by a comprehensive, batch-specific Certificate of Analysis (CoA) detailing quantitative purity assessments with full chromatograms, retention times, and peak area percentages. The CoA further documents residual solvent analysis compliant with ICH Q3C guidelines and heavy metal content limits verified via Inductively Coupled Plasma Mass Spectrometry (ICP-MS).

The compound is supplied as a white to off-white crystalline powder or resinous solid, with physical appearance verified through visual inspection and melting point determination (approximately 78–82 °C for the freebase). This crystalline morphology is critical for accurate weighing and stock solution preparation in analytical workflows. Lower-grade industrial reagents lacking such rigorous characterisation introduce unacceptable variability in transporter inhibition assays, mass spectral library development, and metabolic profiling—compromising data integrity and jeopardising publication in peer-reviewed journals.

For European laboratory managers, this level of purity is non-negotiable. Analytical reference standards used in forensic toxicology method validation or LC-MS/MS library calibration for pyrrolidinophenone novel psychoactive substance (NPS) screening panels demand single dominant peaks with retention time precision of ±0.2 minutes and area-under-curve purity exceeding 98.5%. Pharma Research .eu’s ≥99% specification exceeds this threshold, ensuring reliable quantitation in complex biological matrices and robust inter-laboratory reproducibility across EU member states.

Principal Laboratory Applications and Research Methodologies

Analytical Toxicology and Forensic Chemistry: MDPHP serves as a certified reference material (CRM) for mass spectral library development in LC-MS/MS and GC-MS platforms used by forensic toxicology laboratories across Europe. Its well-characterised fragmentation pattern enables accurate identification in proficiency testing schemes and method validation for pyrrolidinophenone NPS screening panels. The compound’s distinct mass-to-charge ratios (m/z 290.2 [M+H]⁺ for freebase) facilitate differentiation from structurally related cathinones such as MDPV, MDPiHP, and α-PHP in multi-analyte workflows, supporting regulatory compliance with EU early warning system requirements.

In Vitro Dopamine and Norepinephrine Transporter Inhibition Assays: Within controlled cellular models, MDPHP functions as a potent dopamine-norepinephrine reuptake inhibitor (DNRI) with high affinity for both DAT and NET. Published data indicate IC₅₀ values of approximately 50 nM at DAT and 60 nM at NET, with markedly reduced activity at SERT (IC₅₀ ≈ 9,000 nM), demonstrating strong selectivity for catecholamine transporters. Researchers utilise this methylenedioxy-substituted pyrrolidinophenone to investigate structure-activity relationships (SAR) within the cathinone class, quantifying inhibitory potency and selectivity profiles relative to MDPV and other ring-substituted analogues. Such in vitro modelling, conducted exclusively in transfected cell lines (e.g., HEK293 cells expressing human DAT, NET, or SERT), informs mechanistic understanding of monoamine reuptake inhibition without direct receptor agonism.

Metabolic Stability and Metabolite Profiling: In drug metabolism and pharmacokinetics (DMPK) research, MDPHP provides a substrate for in vitro metabolic stability assays using human liver microsomes or recombinant cytochrome P450 enzymes (notably CYP2D6 and CYP3A4). Researchers assess metabolic clearance rates, identify major metabolites (including demethylenylated, pyrrolidine ring-oxidised, and side-chain hydroxylated species) via LC-HRMS, and evaluate potential drug-drug interaction liabilities—all within strictly controlled in vitro frameworks. These studies contribute to predictive ADME modelling for novel central nervous system agents under development by European pharmaceutical R&D consortia and support forensic interpretation of MDPHP detection in biological specimens.

Chemical Synthesis and Reaction Monitoring: As a high-purity building block, MDPHP serves as a reference standard for monitoring synthetic transformations in medicinal chemistry programmes targeting substituted cathinone derivatives. Its defined stereochemistry (racemic mixture at the α-carbon) enables chromatographic method development for enantiomeric separations and quality control of related pyrrolidinophenone analogues. The compound’s stability under standard laboratory conditions supports its use as an internal standard in quantitative analytical workflows for cathinone detection in seized materials or biological specimens.

All applications described herein are exclusively for laboratory research purposes and must be conducted by qualified personnel within appropriate institutional frameworks, such as universities, contract research organisations (CROs), or pharmaceutical R&D facilities operating under EU regulatory oversight.

Compound Stability, Optimal Storage, and Safe Handling Protocols

MDPHP freebase exhibits moderate susceptibility to moisture, light, and oxidative degradation, necessitating stringent storage protocols to maintain analytical integrity over extended periods. The methylenedioxy ring is particularly sensitive to acidic hydrolysis and UV radiation, requiring protection from both factors to preserve chemical identity and purity.

Short-term storage (+4°C): For active projects requiring frequent access, store sealed containers at 2–8°C in a dedicated laboratory refrigerator, protected from ambient light using amber glass vials or aluminium foil wrapping. Ensure containers remain tightly closed between uses to minimise moisture ingress and prevent adsorption of atmospheric contaminants. Under these conditions, the compound retains ≥98% purity for up to 12 months when handled appropriately.

Long-term storage (−20°C or −80°C): For archival storage or infrequently accessed reference standards, maintain crystalline powder at −20°C (standard laboratory freezer) or −80°C (ultra-low temperature freezer) in airtight, light-resistant containers with desiccant packs. This protocol preserves analytical-grade purity for 24–36 months, supporting longitudinal research programmes and inter-laboratory comparison studies. Avoid repeated freeze-thaw cycles, which may induce crystalline phase transitions affecting solubility profiles.

Safe handling prerequisites: All manipulations must occur within a certified chemical fume hood operating at face velocities of 0.4–0.6 m/s. Personnel must wear nitrile gloves (minimum 0.1 mm thickness), safety goggles with side shields, and a laboratory coat compliant with EN 14126 standards. Avoid generating aerosols or dust; use spatulas or weighing boats for transfer rather than direct pouring. In the event of skin contact, rinse immediately with copious water for at least 15 minutes and seek medical attention if irritation persists.

Solubility for stock solution preparation: MDPHP freebase is highly soluble in dimethyl sulfoxide (DMSO), ethanol, methanol, and non-polar organic solvents (e.g., dichloromethane, chloroform) to concentrations of 10 mM or higher. The compound is practically insoluble in cold water; for aqueous working solutions, prepare stock solutions in DMSO or ethanol and dilute into appropriate buffered media immediately before use, ensuring final organic solvent concentrations do not exceed 0.5% v/v to avoid cytotoxic artefacts.

Technical Specifications and Molecular Attributes

Property Specification
IUPAC Name 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)hexan-1-one
CAS Registry Number 776994-64-0 (freebase)
Molecular Formula C₁₇H₂₃NO₃ (freebase)
Exact Mass 289.37 g/mol (freebase)
Physical State and Colour White to off-white crystalline powder or resinous solid
Solubility Profile Highly soluble in DMSO, ethanol, methanol; practically insoluble in cold water
Typical Purity (HPLC) ≥99% (area under curve, UV detection at 220 nm)
Storage Conditions (Long-term) −20°C or −80°C, desiccated, protected from light
Melting Point Approximately 78–82 °C (freebase)
pKa Approximately 8.5 (tertiary amine, pyrrolidine)
LogP Approximately 3.1 (estimated)

This specification table provides laboratory managers with rapid access to critical procurement data, ensuring compatibility with existing analytical workflows and storage infrastructure across EU research institutions.

Pharma Research .eu: Your Premier EU Vendor for High-Purity Reagents

Pharma Research .eu transcends the conventional supplier role, positioning itself as an indispensable partner in European scientific rigour and analytical excellence. Our ISO 9001-certified quality management system governs every stage of the supply chain—from raw material sourcing and synthetic route optimisation to final batch release and customer delivery. This systematic approach ensures consistent, reproducible quality across all MDPHP batches, supporting the integrity of your research programmes.

Our dedicated logistics network provides discreet, temperature-controlled shipping to all 27 EU member states, with customs pre-clearance documentation to eliminate border delays. Shipments are packaged in compliance with IATA dangerous goods regulations where applicable, utilising validated cold-chain solutions for temperature-sensitive materials. Tracking information and estimated delivery windows are provided proactively, enabling seamless integration into your laboratory’s inventory management systems.

Beyond logistics, Pharma Research .eu offers expert customer support from scientifically trained personnel capable of discussing analytical specifications, CoA interpretation, and application-specific guidance. Whether you require clarification on stereochemical purity, assistance with method validation protocols for pyrrolidinophenone detection, or bespoke packaging for multi-site studies, our team provides responsive, technically proficient support aligned with your research objectives.

Choose Pharma Research .eu—not merely as a vendor, but as your trusted collaborator in advancing European laboratory research with uncompromising quality, regulatory compliance, and scientific integrity.


Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Buy MDPHP Powder (freebase)”

Your email address will not be published. Required fields are marked *

Shipping & Delivery

MAECENAS IACULIS

Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.

ADIPISCING CONVALLIS BULUM

  • Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
  • Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
  • Diam parturient dictumst parturient scelerisque nibh lectus.

Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.